Another Step Closer to Genomic-informed Therapeutic Dosing for Tuberculosis Drugs

Am J Respir Crit Care Med. 2024 Jun 15;209(12):1427-1428. doi: 10.1164/rccm.202403-0566ED.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antitubercular Agents* / administration & dosage
  • Antitubercular Agents* / therapeutic use
  • Genomics
  • Humans
  • Tuberculosis / drug therapy

Substances

  • Antitubercular Agents